Why is IMDX Down Today?

IMDX
$3.44
▼ -4.32% ($-0.15)
Last updated: Oct 01, 2026 8:33 PM ET

About Insight Molecular Diagnostics Inc. Common Stock

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA...

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market Cap: $94.16M
Forward P/E: -6.6
52-Week Range: $2.42 - $8.51
Employees: 49

Overall Confidence: 65%

65% Confident

Based on news, social sentiment, options activity, and sector analysis

SECTOR 65% Confidence
🎯 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector moving together
This appears to be a sector-wide move. The IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector is down 1.2% on average.

✅ Move Confirmation

LOW VOLUME 0.9x average volume

UNCONFIRMED - Low volume suggests this move may not be sustainable.

📍 Sector Context

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector: -1.2%

This appears to be a sector-wide move. Most IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES stocks are moving in the same direction.

Market Comparison

IMDX is significantly underperforming the market (-4.5% vs SPY)
S&P 500
SPY
+0.18%
Nasdaq 100
QQQ
+0.31%
IMDX
This Stock
-4.32%
vs S&P 500: -4.5%
vs Nasdaq: -4.63%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, IMDX is expected to trade between:
$3.33 - $3.50

Key Level to Watch

$3.26 support
Watch for breakdown below $3.44

🔔 Get IMDX Alerts

We'll notify you when IMDX's trend changes or a new signal fires.

Last updated: Oct 01, 2026 8:33 PM (-239 minutes ago)
Data refreshes every 30 minutes during market hours

Options Market Insight

Neutral
Options Sentiment
0.75
Put/Call Ratio
227.5%
Implied Volatility
Call Volume: 6,107
Put Volume: 4,574
Total: 10,681

Historical Context

IMDX has moved more than 3.0% down on 65 occasions in the past year.

38.5%
Continuation Rate
25/65 times continued down
+1.46%
Avg Next Day Change
After similar down moves
Last similar move: Sep 28, 2026 (-18.9%) → Next day: +6.3%

Frequently Asked Questions

Why is IMDX stock down today?

This appears to be a sector-wide move. The IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector is down 1.2% on average.

Is IMDX stock a buy or sell right now?

Based on current analysis, IMDX shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →

What is the IMDX stock price target?

IMDX is currently trading at $3.44. Based on today's momentum, the expected short-term range is $3.33 - $3.50. See long-term price prediction →

Will IMDX stock continue falling?

Our analysis shows a 45% probability that IMDX's move continues in the next 1-3 days. Key level to watch: $3.26 (support).

Is IMDX stock oversold or overbought?

IMDX's RSI (Relative Strength Index) is currently at 39.5. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.

What is the momentum for IMDX stock?

IMDX's 10-day momentum indicator is at -0.52. Negative momentum - the stock has mild downward pressure which may continue short-term.

Is IMDX outperforming or underperforming the market?

IMDX (-4.32%) is currently significantly underperforming the market (-4.5% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.

What does MACD indicate for IMDX?

IMDX's MACD (-0.21) is currently below the signal line (-0.18), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 31.2) is strong.

Is IMDX in an uptrend or downtrend?

Based on moving average analysis, IMDX is in a bearish trend. The price ($3.44) is trading below both the 20-day SMA ($3.89) and 50-day SMA ($4.24). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL